Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.

Boneparth A, Radhakrishna SM, Greenbaum LA, Yen E, Okamura DM, Cooper JC, Mason S, Levy DM, Sule SD, Jensen PT, Yildirim-Toruner C, Ardoin SP, Wenderfer SE.

J Rheumatol. 2017 Nov;44(11):1619-1623. doi: 10.3899/jrheum.170502. Epub 2017 Sep 15.

PMID:
28916546
2.

Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure.

Rabik CA, Atkinson MA, Sule S, Strouse JJ.

Transfusion. 2017 Sep;57(9):2159-2163. doi: 10.1111/trf.14185. Epub 2017 Jul 13.

PMID:
28707410
3.

Abnormal body composition, cardiovascular endurance, and muscle strength in pediatric SLE.

Sule S, Fontaine K.

Pediatr Rheumatol Online J. 2016 Sep 5;14(1):50. doi: 10.1186/s12969-016-0110-8.

4.

Increased risk of death in African American patients with end-stage renal disease secondary to lupus.

Sule S, Fivush B, Neu A, Furth S.

Clin Kidney J. 2014 Feb;7(1):40-4. doi: 10.1093/ckj/sft157. Epub 2014 Jan 2.

5.

Abnormal production of pro- and anti-inflammatory cytokines by lupus monocytes in response to apoptotic cells.

Sule S, Rosen A, Petri M, Akhter E, Andrade F.

PLoS One. 2011 Mar 14;6(3):e17495. doi: 10.1371/journal.pone.0017495.

6.

Increased risk of death in pediatric and adult patients with ESRD secondary to lupus.

Sule S, Fivush B, Neu A, Furth S.

Pediatr Nephrol. 2011 Jan;26(1):93-8. doi: 10.1007/s00467-010-1640-9. Epub 2010 Oct 3.

7.

Bullous lupus: an unusual initial presentation of systemic lupus erythematosus in an adolescent girl.

Tincopa M, Puttgen KB, Sule S, Cohen BA, Gerstenblith MR.

Pediatr Dermatol. 2010 Jul-Aug;27(4):373-6. doi: 10.1111/j.1525-1470.2010.01179.x.

PMID:
20653856
8.

Persistent low albumin and temporary vascular access in pediatric patients with SLE on hemodialysis.

Sule SD, Fadrowski JJ, Fivush BA, Neu AM, Furth SL.

Pediatr Nephrol. 2009 Oct;24(10):1981-7. doi: 10.1007/s00467-009-1227-5. Epub 2009 Jun 13.

9.

MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.

Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, Hsu V, Rothfield N, Steen V, Martin RW, Smith E, Mayes M, Simms R, Pope J, Kahaleh B, Csuka ME, Gruber B, Collier D, Sweiss N, Gilbert A, Dechow FJ, Gregory J, Wigley FM.

Arthritis Rheum. 2009 Mar;60(3):870-7. doi: 10.1002/art.24351.

10.

Reduced albumin levels and utilization of arteriovenous access in pediatric patients with systemic lupus erythematosus (SLE).

Sule SD, Fadrowski JJ, Fivush BA, Gorman G, Furth SL.

Pediatr Nephrol. 2007 Dec;22(12):2041-6. Epub 2007 Sep 28.

PMID:
17901989
11.

Preoperative autologous blood donation by arthritis patients is associated with preoperative anemia and perioperative transfusion.

Sule SD, Bartlett S, Parker A, Dorsi M, Towns M, Bathon J.

J Clin Rheumatol. 2004 Oct;10(5):252-8.

PMID:
17043523
12.

Treatment of scleroderma: an update.

Sule SD, Wigley FM.

Expert Opin Investig Drugs. 2003 Mar;12(3):471-82. Review.

PMID:
12605568

Supplemental Content

Loading ...
Support Center